Plain-English translation of NCT06597201 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing a new dialysis solution called in patients whose kidneys no longer work and who receive peritoneal dialysis treatment at home. The medication is mixed with your regular dialysis fluid to help improve your nutrition and muscle strength. Researchers want to see if this treatment helps malnourished dialysis patients feel better and get stronger over three months.
Many people on long-term home dialysis struggle with poor nutrition and muscle loss, which can weaken their overall health and quality of life. This medication may help patients absorb more nutrients during their regular dialysis treatment, addressing a real gap in care for malnourished patients.
You likely qualify if…
You likely don't qualify if…
You will come in for screening visits to make sure you qualify, then be randomly assigned to either the new treatment group or the standard treatment group. If assigned to the new treatment, you will add one bag of the amino acid dialysis solution to your regular morning dialysis routine, while continuing your normal dialysis exchanges throughout the day. You will have blood tests at 30, 60, and 90 days, and detailed nutrition and dialysis quality measurements at the end of three months. The study lasts about 90 days total, and researchers will closely track any side effects or health changes during this time.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China